Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Hong

Showing results (81-90 of 442) with videos related to

Pageof 45
Sort By:
BMJ Open|January 5, 2022
Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health studyRobert M Califf, Celeste Wong, P Murali Doraiswamy, et al.
JCO Precision Oncology|February 1, 2022
Basket Designs: Statistical Considerations for Oncology TrialsAlexander M Kaizer, Joseph S Koopmeiners, Michael J Kane, et al.
Oncology|December 17, 2013
Retreatment after secondary resistance or mixed response: a pilot studyAung Naing, Rishi Agarwal, Gerald Falchook, et al.
Oncotarget|March 9, 2019
Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestionsChen Fu, Dan S Gombos, Jared Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedsideVivek Subbiah, John Slopis, David S Hong, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2021
Moving Beyond 3+3: The Future of Clinical Trial DesignRazelle Kurzrock, Chia-Chi Lin, Tsung-Che Wu, et al.
Human Brain Mapping|January 29, 2016
Sex differences in amygdala shape: Insights from Turner syndromeTamar Green, Kyle C Fierro, Mira M Raman, et al.
Scientific Reports|December 4, 2015
The isolation and characterization of CTC subsets related to breast cancer dormancyMonika Vishnoi, Sirisha Peddibhotla, Wei Yin, et al.
Oncotarget|September 24, 2017
Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestionsChen Fu, Dan S Gombos, Jared Lee, et al.
JCO Precision Oncology|August 11, 2020
Activity of Brigatinib in Crizotinib and Ceritinib-Resistant <i>ROS1-</i> Rearranged Non-Small-Cell Lung CancerAparna Hegde, David S Hong, Amini Behrang, et al.
Pageof 45

Showing results (81-90 of 442) with videos related to

Sort By:
Pageof 45
BMJ Open|January 5, 2022
Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health studyRobert M Califf, Celeste Wong, P Murali Doraiswamy, et al.
JCO Precision Oncology|February 1, 2022
Basket Designs: Statistical Considerations for Oncology TrialsAlexander M Kaizer, Joseph S Koopmeiners, Michael J Kane, et al.
Oncology|December 17, 2013
Retreatment after secondary resistance or mixed response: a pilot studyAung Naing, Rishi Agarwal, Gerald Falchook, et al.
Oncotarget|March 9, 2019
Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestionsChen Fu, Dan S Gombos, Jared Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedsideVivek Subbiah, John Slopis, David S Hong, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2021
Moving Beyond 3+3: The Future of Clinical Trial DesignRazelle Kurzrock, Chia-Chi Lin, Tsung-Che Wu, et al.
Human Brain Mapping|January 29, 2016
Sex differences in amygdala shape: Insights from Turner syndromeTamar Green, Kyle C Fierro, Mira M Raman, et al.
Scientific Reports|December 4, 2015
The isolation and characterization of CTC subsets related to breast cancer dormancyMonika Vishnoi, Sirisha Peddibhotla, Wei Yin, et al.
Oncotarget|September 24, 2017
Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestionsChen Fu, Dan S Gombos, Jared Lee, et al.
JCO Precision Oncology|August 11, 2020
Activity of Brigatinib in Crizotinib and Ceritinib-Resistant <i>ROS1-</i> Rearranged Non-Small-Cell Lung CancerAparna Hegde, David S Hong, Amini Behrang, et al.
Pageof 45